Table 2.
Clinical setting | CTC+ (%) at baseline (T0) |
CTC+ (%) after the 1st cycle of therapy (T1) |
CTC+ (%) after the 2nd cycle of therapy (T2) |
---|---|---|---|
M 0 | 4/16 (25.0%) | 9/15 (60.0%) | 10/16 (62.5%) |
M + | 27/47 (57.4%) | 32/37 (86.5%) | 16/25 (64.0%) |
M1 | 18/33 (54.6%) | 21/26 (80.8%) | 16/25 (64.0%) |
M2 | 9/14 (64.3%) | 11/11 (100%) | — |
Total | 31/63 (49.2%) | 41/52 (78.8%) | 26/41 (63.4%) |